Information  X 
Enter a valid email address

EPIC/TIDM matching '0FAU'

Date
Time Source
Company
Announcement
01 Mar 2021 9:14 pm EQS Factsheet MorphoSys AG (0FAU) Ad hoc: MorphoSys AG preliminary results for the fiscal year 2020 exceeding guidance
26 Feb 2021 9:10 am EQS Factsheet MorphoSys AG (0FAU) Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
  8:57 am EQS Factsheet MorphoSys AG (0FAU) Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
25 Feb 2021 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
28 Dec 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
10 Dec 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
09 Dec 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
27 Nov 2020 3:30 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Nov 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
24 Nov 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
23 Nov 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
18 Nov 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
06 Nov 2020 12:02 pm EQS Factsheet MorphoSys AG (0FAU) Correction of a release from 05/11/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  12:00 pm EQS Factsheet MorphoSys AG (0FAU) Correction of a release from 05/11/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
05 Nov 2020 3:04 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:02 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30 Oct 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
28 Oct 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
27 Oct 2020 7:21 pm EQS Factsheet MorphoSys AG (0FAU) Ad hoc: MorphoSys AG Raises its Financial Guidance for the Full Year 2020
16 Oct 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
13 Oct 2020 6:45 am EQS Factsheet MorphoSys AG (0FAU) Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
09 Oct 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
01 Oct 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
24 Sep 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
22 Sep 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
16 Sep 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 Sep 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
07 Sep 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
18 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
17 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
13 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
12 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
11 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
07 Aug 2020 3:30 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
03 Aug 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
01 Aug 2020 12:35 am EQS Factsheet MorphoSys AG (0FAU) Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
31 Jul 2020 9:00 am EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 Jul 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
07 Jul 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
02 Jul 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  2:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Jun 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
25 Jun 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
24 Jun 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
22 Jun 2020 3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
18 Jun 2020 3:05 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
15 Jun 2020 4:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
09 Jun 2020 4:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  3:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  2:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
05 Jun 2020 2:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
04 Jun 2020 2:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
28 May 2020 4:00 pm EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
  11:36 am EQS Factsheet MorphoSys AG (0FAU) Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


Company Announcements Archive »


a d v e r t i s e m e n t